Acceptance rate | 46% |
---|---|
Time to first decision | 5 days* |
Time to decision with review | 50 days* |
*approximate number of days
ACTA Pharmaceutica Sciencia
2021 , Vol 59 , Num 3
Stability Indicating Method Development and Validation of Ranolazine Extended Release Tablets
1 Istanbul University, Faculty of Pharmacy, Pharmaceutical Technology Dept., Beyazıt, Istanbul, Turkey2 Biopharma Pharmaceutical, Istanbul, Turkey
DOI : 10.23893/1307-2080.APS.05925 Keywords :